Literature DB >> 20077002

Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.

Kentaro Kato1, Hideyuki Takeuchi, Akira Kanoh, Naoki Miyahara, Yoko Nemoto-Sasaki, Megumi Morimoto-Tomita, Azusa Matsubara, Yoshimi Ohashi, Michihiko Waki, Katsuaki Usami, Ulla Mandel, Henrik Clausen, Nobuaki Higashi, Tatsuro Irimura.   

Abstract

O-glycosylation of mucin is initiated by the attachment of N-acetyl-D-galactosamine (GalNAc) to serine or threonine residues in mucin core polypeptides by UDPGalNAc:polypeptide N-acetylgalactosaminyltransferases (ppGalNAc-Ts). It is not well understood how GalNAc attachment is regulated by multiple ppGalNAc-Ts in each cell. In the present study, the expression levels of murine ppGalNAc-Ts (mGalNAc-Ts), T1, T2, T3, T4, T6, and T7 were compared between mouse colon carcinoma colon 38 cells and variant SL4 cells, selected for their metastatic potentials, by using the competitive RT-PCR method. The expression levels of mGalNAc-T1, T2, and T7 were slightly higher in the SL4 cells than in the colon 38 cells, whereas the expression level of mGalNAc-T3 in the SL4 cells was 1.5% of that in the colon 38 cells. Products of enzymatic incorporations of GalNAc residues into FITCPTTTPITTTTK peptide by the use of microsome fractions of these cells as the enzyme source were separated and characterized for the number of attached GalNAc residues and their positions. The maximum number of attached GalNAc residues was 6 and 4 when the microsome fractions of the colon 38 cells and SL4 cells were used, respectively. When the microsome fractions of the colon 38 cells were treated with a polyclonal antibody raised against mGalNAc-T3, the maximum number of incorporated GalNAc residues was 4. These results strongly suggest that mGalNAc-T3 in colon 38 cells is involved in additional transfer of GalNAc residues to this peptide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20077002     DOI: 10.1007/s10719-009-9275-4

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  42 in total

1.  Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model.

Authors:  Y Nemoto-Sasaki; M Mitsuki; M Morimoto-Tomita; A Maeda; M Tsuiji; T Irimura
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

2.  Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth.

Authors:  Megumi Morimoto-Tomita; Yoshimi Ohashi; Azusa Matsubara; Makoto Tsuiji; Tatsuro Irimura
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

3.  Dipeptidyl aminotransferase activity and in vitro O-glycosylation of MUC5AC mucin motif peptides by human gastric microsomal preparations.

Authors:  B Soudan; D Tetaert; S Hennebicq; G Briand; F Zerimech; C Richet; D Demeyer; J Gagnon; Y Petillot; P Degand
Journal:  J Pept Res       Date:  1998-05

4.  Distinct orders of GalNAc incorporation into a peptide with consecutive threonines.

Authors:  K Kato; H Takeuchi; N Miyahara; A Kanoh; H Hassan; H Clausen; T Irimura
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

5.  Functional conservation of subfamilies of putative UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases in Drosophila, Caenorhabditis elegans, and mammals. One subfamily composed of l(2)35Aa is essential in Drosophila.

Authors:  Tilo Schwientek; Eric P Bennett; Carlos Flores; John Thacker; Martin Hollmann; Celso A Reis; Jane Behrens; Ulla Mandel; Birgit Keck; Mireille A Schäfer; Kim Haselmann; Roman Zubarev; Peter Roepstorff; Joy M Burchell; Joyce Taylor-Papadimitriou; Michael A Hollingsworth; Henrik Clausen
Journal:  J Biol Chem       Date:  2002-03-29       Impact factor: 5.157

6.  Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.

Authors:  E P Bennett; H Hassan; U Mandel; M A Hollingsworth; N Akisawa; Y Ikematsu; G Merkx; A G van Kessel; S Olofsson; H Clausen
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

7.  Expression of UDP-N-acetyl-alpha-D-galactosamine-polypeptide galNAc N-acetylgalactosaminyl transferase-3 in relation to differentiation and prognosis in patients with colorectal carcinoma.

Authors:  Kazunori Shibao; Hiroto Izumi; Yoshifumi Nakayama; Ryo Ohta; Naoki Nagata; Minoru Nomoto; Ken-ichi Matsuo; Yuji Yamada; Kenji Kitazato; Hideaki Itoh; Kimitoshi Kohno
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

8.  Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23.

Authors:  Yaacov Frishberg; Nobuaki Ito; Choni Rinat; Yuji Yamazaki; Sofia Feinstein; Itaru Urakawa; Paulina Navon-Elkan; Rachel Becker-Cohen; Takeyoshi Yamashita; Kaori Araya; Takashi Igarashi; Toshiro Fujita; Seiji Fukumoto
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

9.  Cloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeat.

Authors:  E P Bennett; H Hassan; U Mandel; E Mirgorodskaya; P Roepstorff; J Burchell; J Taylor-Papadimitriou; M A Hollingsworth; G Merkx; A G van Kessel; H Eiberg; R Steffensen; H Clausen
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  Cloning and characterization of a novel UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase, pp-GalNAc-T14.

Authors:  Han Wang; Kouichi Tachibana; Yan Zhang; Hiroko Iwasaki; Akihiko Kameyama; Lamei Cheng; Jian ming Guo; Toru Hiruma; Akira Togayachi; Takashi Kudo; Norihiro Kikuchi; Hisashi Narimatsu
Journal:  Biochem Biophys Res Commun       Date:  2003-01-17       Impact factor: 3.575

View more
  11 in total

1.  Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.

Authors:  Katrine T Schjoldager; Hiren J Joshi; Yun Kong; Christoffer K Goth; Sarah Louise King; Hans H Wandall; Eric P Bennett; Sergey Y Vakhrushev; Henrik Clausen
Journal:  EMBO Rep       Date:  2015-11-13       Impact factor: 8.807

2.  Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.

Authors:  Thomas A Gerken; Oliver Jamison; Cynthia L Perrine; Jeremy C Collette; Helen Moinova; Lakshmeswari Ravi; Sanford D Markowitz; Wei Shen; Himatkumar Patel; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

Review 3.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

4.  miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

Authors:  Avital Gaziel-Sovran; Miguel F Segura; Raffaella Di Micco; Mary K Collins; Douglas Hanniford; Eleazar Vega-Saenz de Miera; John F Rakus; John F Dankert; Shulian Shang; Robert S Kerbel; Nina Bhardwaj; Yongzhao Shao; Farbod Darvishian; Jiri Zavadil; Adrian Erlebacher; Lara K Mahal; Iman Osman; Eva Hernando
Journal:  Cancer Cell       Date:  2011-07-12       Impact factor: 31.743

5.  2-Acetamido-N-benzyl-1,4-imino-1,2,4-tride-oxy-l-xylitol (N-benzyl-l-XYLNAc).

Authors:  Sarah F Jenkinson; Elizabeth V Crabtree; Andreas F G Glawar; Terry D Butters; George W J Fleet; David J Watkin
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-24

Review 6.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

7.  Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.

Authors:  Zhi-Qiang Wang; Magdalena Bachvarova; Chantale Morin; Marie Plante; Jean Gregoire; Marie-Claude Renaud; Alexandra Sebastianelli; Dimcho Bachvarov
Journal:  Oncotarget       Date:  2014-01-30

8.  Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer.

Authors:  Luis Ubillos; Edgardo Berriel; Daniel Mazal; Sabina Victoria; Enrique Barrios; Eduardo Osinaga; Nora Berois
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

9.  Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification.

Authors:  Shilei Zhao; Tao Guo; Jinxiu Li; Hidetaka Uramoto; Hongwei Guan; Wuguo Deng; Chundong Gu
Journal:  Onco Targets Ther       Date:  2015-10-27       Impact factor: 4.147

10.  Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.

Authors:  Seema Chugh; Jane Meza; Yuri M Sheinin; Moorthy P Ponnusamy; Surinder K Batra
Journal:  Br J Cancer       Date:  2016-05-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.